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abstract
The main objective of this work is to model and to debottleneck a batch pharmaceutical production with computer-aided process 
design (CAPD) and simulation tools.  An eye drop production case study is firstly modelled based on a pharmaceutical production 
plant.  Throughput analysis is next utilised to identify process bottlenecks that limit the increase of production and to evaluate 
different debottlenecking schemes. Scheme 1 considers an effort to maximise process throughput for a single batch operation, while 
Schemes 2 and 3 explore the possibility of minimising combined utilisation value of the process bottleneck. With the increase of 
batch throughput, installation of a new labelling process and the addition of an intermediate tank, Scheme 3 is identified as the 
debottlenecking scheme that achieves the increased production demand of 25%.    
Keywords:  Batch Processing, Debottlenecking, Modelling and Optimisation, Pharmaceutical Production, Throughput Analysis   
1.0  INTRODUCTION
Computer Aided Process Design (CAPD) and simulation 
tools have been widely used in the bulk and petrochemical 
industries since the early 1960’s.  It involves the use of computers 
to perform steady-state heat and mass balancing as well as 
sizing and costing calculations for a process [1].  However, 
the use of these CAPD and simulation tools has only emerged 
in the pharmaceutical manufacturing in the past decade [2-9]. 
Compared to the readily available process simulators in the bulk 
and petrochemical industries, there are only a limited number 
of simulators available for pharmaceutical process modelling. 
This includes Batches by Batch Process Technologies, Batch 
Plus by Aspen Technology, SuperPro Designer by Intelligen as 
well as Batch Design Kit by Hyprotech.  This situation is mainly 
due to the uncommon unit operations and the batch operation 
nature of pharmaceutical processing.  Due to its relatively new 
emergence, more work needs to be done in this sector. 
This paper describes the use of a batch process simulation tool 
in modelling and debottlenecking of an eye-drop production at 
a pharmaceutical facility.  Due to increasing customer demand 
of the eye-drop product, the pharmaceutical plant authority 
is looking for alternative expansion schemes to increase the 
production rate for an addition of 25% of the existing capacity. 
As the production capacity is limited by current operating 
condition and equipment setup, a debottlenecking study is 
needed for an increase in production.  
2.0  BACKGROUND THEORY
In order to increase process throughput, process bottleneck that 
limit the current production need to be identified.  Bottlenecks are 
process limitations that are related to either equipment or resources 
(e.g. demand for various utilities, labour and raw material).  Hence, 
process debottlenecking can be defined as the identification and 
removal of obstacles in the attempt to increase the plant throughput 
[5]. In batch manufacturing, two types of process bottlenecks 
are encountered.  These are the equipment capacity-related size 
bottleneck (an equipment that is limited in size) as well as the 
scheduling bottleneck (due to the long occupancy of an equipment 
during a process) [5]. The ability to identify and remove process 
bottlenecks that create obstacles in a manufacturing process will 
increase plant throughput and fulfil customer needs.  
A good tool to identify batch process bottleneck is throughput 
analysis study. Throughput analysis measures the equipment 
utilisation in a batch process with two variables, i.e. the capacity 
utilisation and equipment uptime [5-6]. Capacity utilisation 
is defined as the percentage of the current operating load of an 
equipment (e.g. vessel volume for a reactor or filtering area of a 
filter) relative to its maximum load, i.e.:  
   
Equipment capacity utilisation =                                    x 100%     (1)
   
For instance, a vessel with 100% capacity utilisation means that 
its current content has reached to its maximum level.  On the other 
hand, equipment uptime measures the effectiveness of a piece of 
equipment that is utilised in time.  It is given as the percentage of the 
equipment utilisation time over the plant cycle time, i.e.:
   
Equipment uptime =                                                        (2)
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Actual capacity
Maximum capacity
Plant cycle time 
Total time equipment is
utilised per batch
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For example, a reactor that operates for 5 hours within a batch 
process with a cycle time of 10 hours has an uptime of 50%. The 
product of equipment capacity utilisation and its uptime defines 
the combined utilisation of the respective equipment [5-6].  
In an ideal situation, a plant should have all equipment 
running at 100% combined utilisation to achieve maximum 
production. However, this is often not the case. All process 
equipment will normally feature different utilisation. The 
ability to raise utilisation of the equipment will help in raising 
process throughput.  Processing step with the highest combined 
utilisation is normally identified as the first candidate for 
process debottlenecking [5, 9]. CAPD and simulation tools 
that are capable of tracking capacity utilisation and equipment 
uptime can facilitate the identification of process bottlenecks 
and the development of various debottlenecking scenarios. A 
pharmaceutical production of liquid eye drop is used to illustrate 
the concept.  
3.0  MODEL DEVELOPMENT – LIqUID EYE 
DROP PRODUCTION  
Figure 1 shows the base case simulation flowsheet for 
the production of eye drop modelled in SuperPro Designer 
v6.0 [10]. The base case simulation model was developed to 
reflect the actual operating condition in the pharmaceutical 
manufacturing facility that is operated in batch processing 
mode. In the modelling environment of SuperPro Designer, 
this involves the modelling of a few operations that take place 
sequentially in a single unit procedure [10]. In the base case 
model, the production capacity for a single batch is estimated as 
60 L of liquid eye drop. As shown in Figure 1, there are ten major 
processing steps in three different sub-sections. This includes 
deionised water (DI) storing tank (P-1/V-101), pheny blending 
(P-2/V-102), SDP, DHP, SM and NEO blending (P-3/V-103) 
and active ingredient blending (P-4/V-104) in the Pre-Blending 
Section; raw materials blending in the Main Blending Section 
(P-5/V-105); as well as pressurisation (P-6/HP-101), filling (P-7/
FL-101), labelling (P-8/LB-101), and carton packaging (P-9/
BX-101) in the Packaging sections. All raw materials charging 
are carried out at room temperature. Table 1 shows the main 
specification of the equipment that is modelled as rating mode 
in the simulation software.
At the beginning of the manufacturing process, (DI) is 
stored in the storage tank V-101 before being transferred into 
the other Pre-Blending Tanks (V-102, V-103, V-104) and the 
Table 1:  Major equipment specification
quantity Procedure/
Equipment
Specification
Pre-Blending section
1 P-1/V-101 Volume = 90 L
1 P-2/V-102 Volume = 10 L
1 P-3/V-103 Volume = 80 L
1 P-4/V-104 Volume = 5 L
Main Blending section
1 P-5/V-105 Volume = 90 L
Packaging section
1 P-6/HL-101 Maintain as in design mode
1 P-7/FL-101 Rated throughput = 40 entities/minute
1 P-8/LB-101 Rated throughput = 30 entities/minute
1 P-9/BX-101 Rated throughput = 5 entities/min
Figure 1: Base case simulation flowsheet
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Main Blending Tank (V-105). The agitation processes in each 
Pre-Blending Tank is carried out manually. Upon the completion 
of the transfer-in operation from all Pre-Blending tanks to the 
Main Blending Tank, the products are once again blended 
to obtain uniform composition before the product mixture is 
sent to the Packaging Section.  In the Packaging Section, the 
blended product from the Main Blending Tank is first undergo 
pressurisation (P-6/HP-101) before it is filled into the 5 mL 
bottle in the filling procedure (P-7/FL-101).  The bottles are then 
sent to the labelling procedure (P-8/LB-101) and followed by 
carton packaging procedure (P-9/BX-101) where the eye drop 
bottles are packed manually into the carton boxes with 12 bottles 
per box.  
As the manufacturing process is carried out in a batch operation 
mode, efforts have been made to document the scheduling details 
of each processing steps.  This includes the setup time, process 
time, and start time of each individual operation in each unit 
procedure.  Setup time (SUT) is the preparation time needed 
before an operation takes place.  Often, this involves the loading 
of raw material (e.g. from loading area), equipment preparation 
Figure 2:  Operation Gantt Chart for the complete recipe of a single batch operation of eye drop production (number in parenthesis indicate start 
time and end time, as well as the duration for each procedure/operation)
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or setup that often occur in batch processing.  Process time (PT), 
on the other hand, represents the actual processing duration 
needed for each operation. Finally, start time (ST) documents 
the beginning of an operation. It should also be noted that the 
process time for some operations are dependant upon operations 
of other procedure. For instant, duration for transfer out operation 
in P-5 and high pressure operation of P-6 (both regard as “slave” 
operation) are set to follow the filling operation of P-7 (regard 
as “master” operation), using the Master-Slave Relationship 
function of SuperPro Designer v6.0 [10].  Process scheduling 
summary for all procedures in the base case model is shown 
in Table 2.  The Operation Gantt Chart in Figure 2 shows the 
complete recipe of a single batch process.  
   
4.0  BOTTLENECK IDENTIFICATION VIA 
THROUGHPUT ANALYsIs
In the current operation, the annual operating time for the eye 
drop manufacturing is taken as 2080 hours, which is based on 
52 operation weeks, 5 days a week and 8 hours operation per 
day. Increasing daily operating duration is determined to be 
Table 2:  Scheduling summary for operations and procedures in the base case model
Procedure/ 
Equipment
Operation sUT (mins) PT sT
P-1/V-101
Charge DI Water 20 47L/min Beginning of batch
Transfer out to P-2 − 5 min After DI Water charge
Transfer out to P-3 − 10 mins After agitation in P-2
Transfer out to P-4 − 5 mins After agitation in P-3
Transfer out to P-5 − 5 mins After agitation in P-4
CIP − 15 mins Starts with transfer out in P-5 (to P-6)
P-2/V-102
Transfer in from P-1 − Master-Slave with P-2 transfer out in P-1 Starts with P-2 transfer out in P-1
Heating (to 100oC) 5 4°C/min After transfer in from P-1
Charge pheny − 5 mins After heating
Agitation − 5 mins After pheny charge
Cooling (to 27oC) − 2°C/min After agitation 
Transfer out to P-5 − 5 min After transfer out in P-1 (to P-5)
CIP − 15 mins After CIP in P-1
P-3/V-103
Transfer in from P-1 − Master-Slave with P-3 transfer out in P-1 Starts with P-3 transfer out in P-1
Charge NEO − 5 min After transfer in from P-1
Charge SDP − 5 mins After NEO charge 
Charge DHP − 5 mins After SDP charge
Charge SM − 5 min After DHP charge
Agitation − 15 min After SM charge
Transfer out to P-5 − 10 min After transfer out in P-2 (to P-5)
CIP − 15 mins After CIP in P-2
P-4/V-104
Transfer in from P-1 − Master-Slave with P-4 transfer out in P-1 Starts with P-4 transfer out in P-1 
Charge Active Ing − 5 min After transfer in from P-1
Agitation − 10 min After Active Ing charge 
Transfer out to P-5 − 10 kg/min After transfer out in P-3 (to P-5)
CIP − 15 mins After CIP in P-3
P-5/V-105
Transfer in from P-1 − Master-Slave with transfer out in P-1 Starts with transfer out in P-1 (to P-5)
Transfer in from P-2 − Master-Slave with transfer out in P-2 Starts with transfer in from P-2 (to P-5)
Transfer in from P-3 − Master-Slave with transfer out in P-3 Starts with transfer in from P-3 (to P-5)
Transfer in from P-4 − Master-Slave with transfer out in P-4 Starts with transfer in from P-4 (to P-5)
Agitation − 15 min After transfer in from P-4
Transfer out to P-6 − Master-Slave with Filling in P-7 After agitation
P-6/HP-101 Pressurisation − Master-Slave with Filling in P-7 Starts with transfer out in P-5 (to P-6)
P-7/FL-101 Filling (Fill level: 5 mL/
bottle)
30 Calculate based on operating throughput 
of 40 entities/min
Starts with transfer out in P-5 (to P-6)
P-8/LB-101 Labelling − Calculate based on operating throughput 
of 30 entities/min
Starts with filling in P-7
P-9/BX-101 Packing (Boxing capac-
ity: 12 items/box)
30 Calculate based on operating throughput 
of 5 sealed box/min
3 hours after the labelling in P-8 starts
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uneconomical due to the high operating 
cost in hiring additional staff. From 
the base case simulation, a complete 
batch of liquid eye drop is found to 
have a process batch time of 9.51 hrs 
and a minimum cycle time of 6.67 hrs 
(P-8/LB101; Figure 2). The minimum 
cycle time of the process is defined as 
the minimum time possible between 
the start of two consecutive batches, 
and is determined by the procedure 
that occupies the longest duration 
within a batch process [10]. In the 
case of eye drop manufacturing, the 
minimum cycle time corresponds to 
the prolonged labelling procedure 
P-8. With an interval of 2 hrs for tank 
cleaning between batches, this sets the 
plant annual production at 239 batches 
of liquid eye drop product.   
Throughput analysis is utilised 
to identify process bottleneck 
systematically. Figure 3 displays the 
capacity, time and combined utilisation 
of all the procedure/equipment pairs 
in the base case simulation mode 
generated by SuperPro Designer. A few 
observations can be made here.  First, 
all vessels in the Pre-Blending and 
Main Blending Sections (V101-V105) 
are underutilised, with capacity 
utilisation of approximately 70%. 
Hence, debottlenecking strategy should 
firstly aim to fully utilise these vessels 
to increase the batch throughput before 
any new equipment is installed [5]. 
Second, as shown in Figure 3, 
the labelling procedure P-8 
(LB-101) has the highest combined 
utilisation among all procedures, i.e. 
76.9%, due to its equipment capacity 
utilisation of 100% and the equipment 
uptime of 76.9%. The high equipment 
uptime of this procedure is mainly due 
to its slow operating speed (30 labels/
min). This also makes it the scheduling bottleneck of the process, 
i.e. process with longest operating duration (see Operation Gantt 
Chart in Figure 2). Hence, bebottlecking strategies should be 
developed to reduce either size or time utilisation of this process 
bottleneck. The debottlenecking objective has been set by the plant 
authority to increase the eye drop production by 25%. 
5.0  PROCEss DEBOTTLENECKING sCHEMEs
Three debottlenecking schemes were developed and 
analysed using SuperPro Designer v6.0 [10].  In Scheme 1, 
all equipment and machineries in the existing production 
were maintained.  The main strategy in this scheme was to 
increase raw material feed to the process up to the maximum 
capacity of the equipment.  This corresponded to a capacity 
of 80 L eye drop liquid per batch.  Due to the increase of 
process throughput, simulation result showed that the annual 
production for this scheme was decreased to 190 batches due to 
the prolonged minimum cycle time from 6.67 hrs (in the base 
case simulation) to 8.89 hrs.  However, this negative effect of 
the prolonged minimum cycle time (which will lead to reduced 
number of annual batches) is offset by the increase of batch 
throughput of 16001 bottles.  This eventually leads to higher 
production of 3.04 million of eye drop products per annum, 
corresponds to an increase of 6.0% as compared to the base 
case simulation.  From the simulation and throughput analysis 
results (shown in Figure 4), the labelling procedure P-8 was 
determined to remain as the scheduling bottleneck with a 
combined utilisation of 81.6%. Besides, two vessels V-101 and 
V-105 have reached their maximum capacity utilisation to the 
increase of raw material feed.   
Figure 3:  Capacity, time and combined utilisation of base case simulation
Figure 4:  Throughput analysis chart for Scheme 1
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Figure 6:  Simulation flowsheet for debottlenecking Scheme 3
Figure 5:  Simulation flowsheet for debottlenecking Scheme 2
TAN JULLY, et al.
Journal - The Institution of Engineers, Malaysia (Vol. 69, No.4, December 2008)36
Debottlecking Scheme 2 (Figure 5) is built upon Scheme 1 
(with higher batch throughput), where a new labelling machine 
(P-8/LB-101) with a rated throughput of 40 label/min was installed. 
As a result of the higher labelling speed, the equipment update 
uptime is reduced, which leads to lower combined utilisation of 
68.3%. Besides, the combined utilisation for other procedures 
have significantly increased. In other words, these procedures are 
better utilised in the overall context of the process. Simulation 
results reported that an increase of 18.8% was achieved for the 
annual production (3.41 million bottles/year) as compared to the 
base case simulation. With the installation of a new and faster 
labelling machine, the Main Blending Tank (P-5/V-105) appeared 
as the new process bottleneck with a combined utilisation value 
of 78.5%. To further increase the plant annual production, 
debottlenecking should focus on reducing the long duration of the 
transfer out operation in P-5/V-105 (see Figure 2). This will be 
carried out in Scheme 3. 
Scheme 3 for process debottlenecking is shown in Figure 6, 
which is built upon Scheme 2, i.e. with the newly installed 
labelling machine. As shown in Figure 6, where an additional 
intermediate tank (P-610/V-106) is installed between the Main 
Blending Tank (P-5/V-105) and high pressure operation (P-7/
HP-101). The blended eye drop product will be transferred to 
this tank upon the completion of the blending operation in the 
Main Blending Tank (P5/V-101), while feeding the blended 
product to the filling machine. This enables the operations in 
the Pre-Blending and Main Blending Tanks to be carried out 
without having to wait for the completion of the filling operation. 
Simulation results showed that combined utilisation values of 
P-5/V-105 was reduced significantly to 7.2%. Similar to the case 
of Scheme 2, all other procedures demonstrate better utilisation in 
the overall context, represented by the increase of the combined 
utilisation values. The net result is the reduction of minimum 
cycle time to 7.25 hrs and an increased annual production rate 
of 3.58 million bottles, i.e. 25% as compared to the base case. 
Debottlenecking efforts were stopped at this scheme as the 
debottlenecking objective had been reached. Note that for both 
Schemes 2 and 3, it is assumed that the fixed cost of installing 
new equipment is within the capital expenditure limit of the plant 
authority. If the scheme is justified to be implemented, detailed 
economic analysis is to be carried out to evaluate its cost/benefit 
ratio, such as that carried out by previous study [9]. 
All the proposed debottlenecking schemes have demonstrated 
significant improvement on the annual production. Tables 3 and 
4 summarised the process throughput and combined utilisation 
values for the base case simulation as well as all debottlenecking 
schemes. As shown in Table 4, the combined utilisation values 
for all unit procedures are increasing gradually with the proposed 
schemes, with the exceptional case for the process bottleneck 
(value in bold). In other words, by reducing the combined 
utilisation of the debottleneck equipment, the combined utilisation 
of other equipment will be raised, which also means that they 
are better utilised in the overall context of the process.  Finally, 
note that all scheme presented here are bound with the limitation 
that the process is analysed during its steady-state operation. 
Similar exercises will have to be carried out to identify a suitable 
operating scheme. 
6.0  CONCLUsION
In this work, (CAPD) and simulation tools were used in 
the systematic identification of the process bottleneck and 
debottlenecking study. An industrial pharmaceutical of liquid 
eye drop is used to demonstrate the effectiveness of the tools. 
The annual process throughput is increased for 25% with the 
increase of batch throughput, installation of a high speed labelling 
machine and the use of an intermediate tank. n   
Table 3:  Process throughput of all schemes
Table 4:  Combined utilisation values for all unit procedures in different schemes
Throughput parameters Base case scheme 1 scheme 2 scheme 3
  Batch production (bottles/batch)
  Plant batch time (hour)
  Minimum cycle time (hour)
  Number of batches/year 
  Annual production (bottles/yr)
  Increment of production (%)
12,000
9.51
6.67
 239
 2,868,000 
−
16,001
11.57 
8.89 
190 
3,040,190 
6.0
16,001
10.62
7.76
213
3,408,213
18.8
16,001
10.71
7.25
224
3,584,224
25.0
Equipment Tag Procedure Name Base case scheme 1 scheme 2 scheme 3
    P-1 V-101
    P-2 V-102
    P-3 V-103
    P-4 V-104
    P-5 V-105
    P-7 FL-101
    P-8 LB-101
    P-9 BX-101
Pre-Blending 1
Pre-Blending 2
Pre-Blending 3
Pre-Blending 4
Main Blending Tank
Filler
Labeller
Packaging
25.0
17.3
19.3
15.1
52.0
63.5
76.9
44.2
26.6
18.5
20.3
12.1
70.3
65.8
81.6
45.4
29.7
20.7
22.7
13.5
78.5
73.5
68.3
50.7
31.3
21.8
23.9
14.3
7.2
77.5
72.1
53.5
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